International Journal of Infectious Diseases
Volume 11, Issue 2 , Pages 123-128 , March 2007

Polymorphisms and resistance mutations in the protease and reverse transcriptase genes of HIV-1 F subtype Romanian strains

Received 15 July 2005 ,Revised 2 November 2005 ,Accepted 15 November 2005.

References 

  1. Tural C, Ruiz L, Holtzer C, Schapiro J, Viciana P, Gonzales J, et al. Clinical utility of HIV-1 genotyping and expert advice: the Havana trial. AIDS. 2002;16:209–218
  2. Pieniazek D, Rayfield M, Hu D, Nkengasong J, Wiktor S, Downing R, et al. Protease sequences from HIV-1 group M subtypes A–H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naïve individuals worldwide. AIDS. 2000;14:1489–1495
  3. Dumans AT, Soares MA, Pieniazek D, Kalish ML, De Vroey V, Hertogs K, et al. Prevalence of protease and reverse transcriptase drug resistance mutations over time in drug-naïve human immunodeficiency virus type 1-positive individuals in Rio de Janeiro, Brazil. Antimicrob Agents Chemother. 2002;46:3075–3079
  4. Vergne L, Peeters M, Mpoudi-Ngole E, Bourgeois A, Liegeois F, Toure-Kane C, et al. Genetic diversity of protease and reverse transcriptase sequences in non-subtype B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients. J Clin Microbiol. 2000;38:3919–3925
  5. Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, Collier AC, et al. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med. 2002;347:385–394
  6. Turner D, Brenner B, Moisi D, Detorio M, Cesaire R, Kurimura T, et al. Nucleotide and amino acid polymorphism at drug resistance sites in non-B subtype variants of human immunodeficiency virus type 1. Antimicrob Agents Chemother. 2004;48:2993–2998
  7. Pires IL, Soares MA, Speranza FA, Ishii SK, Vieira M, Gouvea M, et al. Prevalence of human immunodeficiency virus drug resistance mutations and subtypes in drug-naive, infected individuals in the army health service of Rio de Janeiro, Brazil. J Clin Microbiol. 2004;42:426–430
  8. Cornelissen M, van der Burg R, Zorgdrager F, Lukashov V, Goudsmit J. pol gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D. J Virol. 1997;71:6348–6358
  9. Apetrei C, Necula A, Holm-Hansen C, Lousert-Ajaka I, Pandrea I, Cozmei C, et al. HIV-1 diversity in Romania. AIDS. 1998;12:1079–1085
  10. Apetrei C, Descamps D, Collin G, Loussert-Ajaka I, Damond F, Duca M, et al. Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility. J Virol. 1998;72:3534–3538
  11. Kantor R, Katzenstein DA, Efron B, Carvalho AP, Wynhoven B, Cane P, et al. Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration. PLoS Med. 2005;2:e112
  12. Otelea D, Oprisan G, Dinu M, Manaila S, Banica D, Tinischi M, et al. Phylogenetic analysis of subtype F HIV-1 strains isolated in Romania. Clin Microbiol Infect. 2004;10(Suppl. 3):160;(poster 667 abstract)
  13. Kumar S, Tamura K, Nei M. MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform. 2004;5:150–163
  14. Tanuri A, Vicente ACP, Otsuki K, Ramos CA, Ferreira OC, Schechter M, et al. Genetic variation and susceptibilities to protease inhibitors among subtype B and F isolates in Brazil. Antimicrob Agents Chemother. 1999;43:253–258
  15. Pillay D, Walker AS, Gibb DM, de Rossi A, Kaye S, Ait-Khaled M, et al. Impact of immunodeficiency virus type 1 subtypes on virologic response and emergence of drug resistance among children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 trial. J Infect Dis. 2002;186:617–625
  16. Spira S, Wainberg MA, Loemba H, Turner D, Brenner BG. Impact of clade diversity on HIV-1 virulence, antiretroviral drug sensitivity and drug resistance. J Antimicrob Chemother. 2003;51:229–240
  17. Descamps D, Collin G, Letourneur F, Apetrei C, Damond F, Loussert-Ajaka I, et al. Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analysis. J Virol. 1997;71:8893–8898
  18. Descamps D, Apetrei C, Collin G, Damond F, Simion F, Brun-Vezinet F. Naturally occurring decreased susceptibility of HIV-1 subtype G to protease inhibitors. AIDS. 1998;12:1109–1111
  19. Otelea D, Manaila S, Dinu M, Banica D, Tinischi M, Maxim D. Prevalence of resistance mutations in subtype F strains isolated from Romanian naïve children. Clin Microbiol Infect. 2004;10(Suppl. 3):160;(poster 666 abstract)
  20. Brindeiro R, Vanderborght B, Caride E, Correa L, Oravec RM, Berro O, et al. Sequence diversity of reverse transcriptase of human immunodeficiency virus type 1 from untreated Brazilian individuals. Antimicrob Agents Chemother. 1999;43:1674–1680

☆ This study was presented in part as a poster at the 14th European Congress of Clinical Microbiology and Infectious Diseases, Prague, May 2004.

PII: S1201-9712(06)00056-7

doi: 10.1016/j.ijid.2005.11.006

International Journal of Infectious Diseases
Volume 11, Issue 2 , Pages 123-128 , March 2007

Article Tools

* Image Usage & Resolution